Effects of oral administration of lactobacillus acidophilus l-92 on the symptoms and serum cytokines of atopic dermatitis in japanese adults: A double-blind, randomized, clinical trial

International Archives of Allergy and Immunology

Volumn 165, Issue 4, 2014, Pages 247-254

  Inoue, Yusuke ^a   Kambara, Takeshi ^b   Murata, Naoko ^a   Komori Yamaguchi, Junko ^a   Matsukura, Setsuko ^b   Takahashi, Yukitoshi ^c   Ikezawa, Zenro ^a   Aihara, Michiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

Atopic dermatitis; Cytokine levels; Lactobacillus acidophilus L 92

Indexed keywords

CYTOKINE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PLACEBO; PROBIOTIC AGENT; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL COUNT; FEMALE; HUMAN; JAPANESE (PEOPLE); LACTOBACILLUS ACIDOPHILUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; SYMPTOM ASSESSMENT; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; JAPAN; MICROBIOLOGY; NONPARAMETRIC TEST;

ADULT; CYTOKINES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; JAPAN; LACTOBACILLUS ACIDOPHILUS; MALE; PROBIOTICS; STATISTICS, NONPARAMETRIC;

EID: 84924280756     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000369806     Document Type: Article

References (33)

1. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, ORegan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGioVanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epiDermal barrier protein filaggrin are a major predisposing factor for atopic Dermatitis. Nat Genet 2006; 38: 441-446
2. Kalliomki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-1079
3. Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ: Gastrointestinal symptoms in atopic eczema. Arch Dis Child 1998; 78: 230
4. Betsi GI, Papadavid E, Falagas ME: Probiotics for the treatment or prevention of atopic Dermatitis: a review of the eviDence from randomized controlled trials. Am J Clin Dermatol 2008; 9: 93-103
5. Brouwer ML, Wolt-Plompen SA, Dubois AE, Van Der HeiDe S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ: No effects of probiotics on atopic Dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006; 36: 899-906
6. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H: Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007; 56: 293-301
7. Torii S, Torii A, Itoh K, Urisu A, Terada A, Fujisawa T, Yamada K, Suzuki H, Ishida Y, Nakamura F, Kanzato H, Sawada D, Nonaka A, Hatanaka M, Fujiwara S: Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic Dermatitis in children. Int Arch Allergy Immunol 2011; 154: 236-245
8. De Roock S, Van Elk M, Van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, Hoekstra MO, De Kleer IM: Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010; 40: 103-110
9. Sudo N, Yu XN, Aiba Y, Oyama N, Sonoda J, Koga Y, Kubo C: An oral introduction of intestinal bacteria prevents the Development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002; 32: 1112-1116
10. Yoshida T, Fujiwara W, Enomoto M, Nakayama S, Matsuda H, Sugiyama H, Shimojoh M, Okada S, Hattori M: An increased number of CD4+ CD25+ cells induced by an oral administration of Lactobacillus plantarum NRIC 0380 are involved in antiallergic activity. Int Arch Allergy Immunol 2013; 162: 283-289
11. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J: Is the effect of probiotics on atopic Dermatitis confined to food sensitized children? Clin Exp Allergy 2006; 36: 629-633
12. Ou CY, Kuo HC, Wang L, Hsu TY, Chuang H, Liu CA, Chang JC, Yu HR, Yang KD: Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2012; 42: 1386-1396
13. Chiba Y, Shida K, Nagata S, Wada M, Bian L, Wang C, Shimizu T, Yamashiro Y, Kiyoshima-Shibata J, Nanno M, Nomoto K: Wellcontrolled proinflammatory cytokine responses of Peyers patch cells to probiotic Lactobacillus casei. Immunology 2010; 130: 352-362
14. Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW, Shek LP: Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol 2014; 163: 25-28
15. Yan F, Polk DB: Probiotics and immune health. Curr Opin Gastroenterol 2011; 27: 496-501
16. Ishida Y, Nakamura F, Kanzato H, Sawada D, Yamamoto N, Kagata H, Oh-Ida M, Takeuchi H, Fujiwara S: Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem 2005; 69: 1652-1660
17. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, Kajimoto O, Fujiwara S: Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88: 527-533
18. Saeki H, Furue M, Furukawa F, et al: GuiDelines for management of atopic Dermatitis. J Dermatol 2009; 36: 563-577
19. Kunz B, Oranje AP, Labreze L, et al: Clinical validation and guiDelines for the SCORAD inDex: consensus report of the European Task Force on atopic Dermatitis. Dermatology 1997; 195: 10-19
20. Schkel K, Dbel T, Bosselmann I: Future treatment options for atopic Dermatitis-small molecules and beyond. J Dermatol Sci 2014; 73: 91-100
21. Mjsberg J, Eidsmo L: Update on innate lymphoid cells in atopic and non-Atopic inflammation in the airways and skin. Clin Exp Allergy 2014; 44: 1033-1043
22. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic Dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-191
23. Flster-Holst R, Mller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von RDen U, Schrezenmeir J, Christophers E, Weichenthal M: Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moDerate to severe atopic Dermatitis. Br J Dermatol 2006; 155: 1256-1261
24. Corthsy B, Gaskins HR, Mercenier A: Crosstalk between probiotic bacteria and the host immune system. J Nutr 2007; 137(3 suppl 2): 781S-790S
25. Kanzato H, Fujiwara S, Ise W, Kaminogawa S, Sato R, Hachimura S: Lactobacillus acidophilus strain L-92 induces apoptosis of antigenstimulated T cells by modulating Dendritic cell function. Immunobiology 2008; 213: 399-408
26. Shah MM, Saio M, Yamashita H, Tanaka H, Takami T, Ezaki T, Inagaki N: Lactobacillus acidophilus strain L-92 induces CD4(+) CD25(+)Foxp3(+) regulatory T cells and suppresses allergic contact Dermatitis. Biol Pharm Bull 2012; 35: 612-616
27. Chen W, Jin W, HarDegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886
28. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH: Generation of regulatory Dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorDers. Proc Natl Acad Sci U S A 2010; 107: 2159-2164
29. Ishida Y, Bandou I, Kanzato H, Yamamoto N: Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci Biotechnol Biochem 2003; 67: 951-957
30. Shah MM, Miyamoto Y, Yamada Y, Yamashita H, Tanaka H, Ezaki T, Nagai H, Inagaki N: Orally supplemented Lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2, 4-dinitroflurobenzene and mite fecal antigen induced atopic Dermatitis-like skin lesions in mice. Microbiol Immunol 2010; 54: 523-533
31. Smits HH, Engering A, Van Der Kleij D, De Jong EC, Schipper K, Van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, Van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-proucing regulatory T cells in vitro by modulating Dendritic cell function through Dendritic cell-specific intracellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-1267
32. Ashida N, Yanagihara S, Shinoda T, Yamamoto N: Characterization of adhesive molecule with affinity to Caco-2 cells in Lactobacillus acidophilus by proteome analysis. J Biosci Bioeng 2011; 112: 333-337
33. Kuwana R, Yamamoto N: Increases in GroES and GroEL from Lactobacillus acidophilus L-92 in response to a Decrease inmedium pH, and changes in cytokine release from splenocytes: transcriptome and proteomeanalyses. J Biosci Bioeng 2012; 114: 9-16